Qi Y - Search Results

1

FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A.

Yang H, Li M, Qi Y. Yang H, et al. Among authors: qi y. Hum Cell. 2023 May;36(3):1120-1134. doi: 10.1007/s13577-023-00876-9. Epub 2023 Apr 4. Hum Cell. 2023. PMID: 37016167

2

Endometrioid adenocarcinoma of the rectovaginal septum with invasion of the rectum: a case report and review of literature.

Yang H, Gu JJ, Qi Y, Zhao W, Wang XL. Yang H, et al. Among authors: qi y. World J Surg Oncol. 2019 Dec 4;17(1):206. doi: 10.1186/s12957-019-1743-0. World J Surg Oncol. 2019. PMID: 31801560 Free PMC article. Review.

3

Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.

Yang H, Qi Y, Wang XL, Gu JJ, Shi TM. Yang H, et al. Among authors: qi y. Mol Cell Biochem. 2020 Apr;467(1-2):95-105. doi: 10.1007/s11010-020-03704-y. Epub 2020 Feb 24. Mol Cell Biochem. 2020. PMID: 32095930

4

RNA modification regulators as promising biomarkers in gynecological cancers.

Qi Y, Li T, Zhou Y, Hao Y, Zhang J. Qi Y, et al. Cell Biol Toxicol. 2024 Oct 29;40(1):92. doi: 10.1007/s10565-024-09924-y. Cell Biol Toxicol. 2024. PMID: 39472384 Free PMC article. Review.

5

Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.

Liu J, Zheng M, Qi Y, Wang H, Liu M, Liu Q, Lin B. Liu J, et al. Among authors: qi y. Int J Oncol. 2018 Oct;53(4):1774-1786. doi: 10.3892/ijo.2018.4496. Epub 2018 Jul 20. Int J Oncol. 2018. PMID: 30066907

6

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis.

Gao L, Nie X, Zhang W, Gou R, Hu Y, Qi Y, Li X, Liu Q, Liu J, Lin B. Gao L, et al. Among authors: qi y. Cancer Cell Int. 2020 Jun 24;20:268. doi: 10.1186/s12935-020-01359-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32587476 Free PMC article.

7

Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways.

Wang CX, Xiong HF, Wang S, Wang J, Nie X, Guo Q, Li X, Qi Y, Liu JJ, Lin B. Wang CX, et al. Among authors: qi y. Am J Transl Res. 2020 Jul 15;12(7):3557-3576. eCollection 2020. Am J Transl Res. 2020. PMID: 32774719 Free PMC article.

8

Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer.

Gao L, Nie X, Gou R, Qi Y, Liu J, Lin B. Gao L, et al. Among authors: qi y. J Cancer. 2021 Oct 30;12(24):7422-7435. doi: 10.7150/jca.62440. eCollection 2021. J Cancer. 2021. PMID: 35003362 Free PMC article.

9

Depleting TMED3 alleviates the development of endometrial carcinoma.

Zhang J, Qi Y. Zhang J, et al. Among authors: qi y. Cancer Cell Int. 2022 Jul 19;22(1):231. doi: 10.1186/s12935-022-02649-0. Cancer Cell Int. 2022. PMID: 35854294 Free PMC article.

10

Tripartite motif containing 33 demonstrated anticancer effect by degrading c‑Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.

Qi Y, Ma N, Zhang J. Qi Y, et al. Int J Oncol. 2023 Dec;63(6):133. doi: 10.3892/ijo.2023.5581. Epub 2023 Oct 20. Int J Oncol. 2023. PMID: 37859625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,424 results

Search Page

Filters